Robert Fabregat – CEO, Biocat

Robert Fabregat, CEO of Biocat, explains how health start-ups in the BioRegion of Catalonia managed to raise a record EUR 238 million in 2021 and why the Spanish region is set to become a hub for advanced therapies and personalized medicine. In addition, the CEO boasts about Cataolina being at the top in terms of scientific publications and ERC grants compared to countries with a similar size such as Denmark and Finland.  
Catalonia is special for the heterogeneity of its ecosystem. The region has excellent research centres with results that are competitive with the rest of Europe
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report